Biodesix, Aetna sales and marketing update

Aetna issued a positive coverage decision for Biodesix’s blood-based proteomic test VeriStrat for advanced non-small cell lung cancer (NSCLC) patients without EGFR and anaplastic lymphoma kinase (A...